• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

甲状旁腺激素间歇性和持续性给药对骨组织形态计量学及基因表达的不同影响。

Differential effects of intermittent and continuous administration of parathyroid hormone on bone histomorphometry and gene expression.

作者信息

Lotinun Sutada, Sibonga Jean D, Turner Russell T

机构信息

Department of Orthopedics, Mayo Clinic, Rochester, MN 55905, USA.

出版信息

Endocrine. 2002 Feb;17(1):29-36. doi: 10.1385/ENDO:17:1:29.

DOI:10.1385/ENDO:17:1:29
PMID:12014700
Abstract

A mechanism explaining the differential skeletal effects of intermittent and continuous elevation of serum parathyroid hormone (PTH) remains elusive. Intermittent PTH increases bone formation and bone mass and is being investigated as a therapy for osteoporosis. By contrast, chronic hyperparathyroidism results in the metabolic bone disease osteitis fibrosa characterized by osteomalacia, focal bone resorption, and peritrabecular bone marrow fibrosis. Intermittent and continuous PTH have similar effects on the number of osteoblasts and bone-forming activity. Many of the beneficial as well as detrimental effects of the hormone appear to be mediated by osteoblast-derived growth factors. This hypothesis was tested using cDNA microgene arrays to compare gene expression in tibia of rats treated with continuous and pulsatile administration of PTH. These treatments result in differential expression of many genes, including growth factors. One of the genes whose steady-state mRNA levels was increased by continuous but not pulsatile administration was platelet-derived growth factor-A (PDGF-A). Administration of a PDGF-A antagonist greatly reduced bone resorption, osteomalacia, and bone marrow fibrosis in a rat model for hyperparathyroidism, suggesting that PDGF-A is a causative agent for this disease. These findings suggest that profiling changes in gene expression can help identify the metabolic pathways responsible for the skeletal responses to the hormone.

摘要

间歇性和持续性血清甲状旁腺激素(PTH)升高对骨骼产生不同影响的机制仍不清楚。间歇性PTH可增加骨形成和骨量,目前正作为一种骨质疏松症治疗方法进行研究。相比之下,慢性甲状旁腺功能亢进会导致以骨软化、局灶性骨吸收和骨小梁周围骨髓纤维化为特征的代谢性骨病——纤维性骨炎。间歇性和持续性PTH对成骨细胞数量和骨形成活性有相似的影响。该激素的许多有益和有害作用似乎都是由成骨细胞衍生的生长因子介导的。使用cDNA微基因阵列比较连续和脉冲式给予PTH的大鼠胫骨中的基因表达,对这一假说进行了验证。这些处理导致许多基因的差异表达,包括生长因子。血小板衍生生长因子-A(PDGF-A)是连续而非脉冲式给药后其稳态mRNA水平升高的基因之一。在甲状旁腺功能亢进大鼠模型中,给予PDGF-A拮抗剂可大大减少骨吸收、骨软化和骨髓纤维化,这表明PDGF-A是该疾病的致病因子。这些发现表明,分析基因表达变化有助于确定导致骨骼对该激素产生反应的代谢途径。

相似文献

1
Differential effects of intermittent and continuous administration of parathyroid hormone on bone histomorphometry and gene expression.甲状旁腺激素间歇性和持续性给药对骨组织形态计量学及基因表达的不同影响。
Endocrine. 2002 Feb;17(1):29-36. doi: 10.1385/ENDO:17:1:29.
2
Triazolopyrimidine (trapidil), a platelet-derived growth factor antagonist, inhibits parathyroid bone disease in an animal model for chronic hyperparathyroidism.三唑并嘧啶(曲匹地尔)是一种血小板衍生生长因子拮抗剂,在慢性甲状旁腺功能亢进动物模型中可抑制甲状旁腺性骨病。
Endocrinology. 2003 May;144(5):2000-7. doi: 10.1210/en.2002-221000.
3
The effects of programmed administration of human parathyroid hormone fragment (1-34) on bone histomorphometry and serum chemistry in rats.人甲状旁腺激素片段(1-34)程序化给药对大鼠骨组织形态计量学和血清化学指标的影响。
Endocrinology. 1997 Nov;138(11):4607-12. doi: 10.1210/endo.138.11.5505.
4
In vivo parathyroid hormone treatments and RNA isolation and analysis.体内甲状旁腺激素治疗以及RNA的分离与分析。
Methods Mol Biol. 2008;455:79-87. doi: 10.1007/978-1-59745-104-8_5.
5
Continuous parathyroid hormone and estrogen administration increases vertebral cancellous bone volume and cortical width in the estrogen-deficient rat.持续给予甲状旁腺激素和雌激素可增加雌激素缺乏大鼠的椎骨松质骨体积和皮质宽度。
J Bone Miner Res. 2001 Jul;16(7):1300-7. doi: 10.1359/jbmr.2001.16.7.1300.
6
Osteitis fibrosa is mediated by Platelet-Derived Growth Factor-A via a phosphoinositide 3-kinase-dependent signaling pathway in a rat model for chronic hyperparathyroidism.在慢性甲状旁腺功能亢进大鼠模型中,纤维性骨炎由血小板衍生生长因子-A通过磷脂酰肌醇3-激酶依赖性信号通路介导。
Endocrinology. 2008 Nov;149(11):5735-46. doi: 10.1210/en.2008-0134. Epub 2008 Jul 17.
7
Differential transcriptional effects of PTH and estrogen during anabolic bone formation.在合成代谢性骨形成过程中甲状旁腺激素(PTH)和雌激素的差异转录效应。
J Cell Biochem. 2004 Oct 15;93(3):476-90. doi: 10.1002/jcb.20174.
8
Effects of intermittent parathyroid hormone (PTH) administration on SOST mRNA and protein in rat bone.间歇性给予甲状旁腺激素(PTH)对大鼠骨骼中sost信使核糖核酸(mRNA)和蛋白质的影响。
J Mol Histol. 2007 Aug;38(4):261-9. doi: 10.1007/s10735-007-9096-3. Epub 2007 Jun 5.
9
Downregulation of parathyroid hormone receptor gene expression and osteoblastic dysfunction associated with skeletal resistance to parathyroid hormone in a rat model of renal failure with low turnover bone.在低转换骨的肾衰竭大鼠模型中,甲状旁腺激素受体基因表达下调及成骨细胞功能障碍与骨骼对甲状旁腺激素抵抗相关。
Nephrol Dial Transplant. 2005 Sep;20(9):1904-11. doi: 10.1093/ndt/gfh876. Epub 2005 Jun 28.
10
Intermittent administration of parathyroid hormone (1-37) improves growth and bone mineral density in uremic rats.间歇性给予甲状旁腺激素(1-37)可改善尿毒症大鼠的生长和骨矿物质密度。
Kidney Int. 2000 Apr;57(4):1484-92. doi: 10.1046/j.1523-1755.2000.00993.x.

引用本文的文献

1
Phase 1 clinical trial of eneboparatide, a novel PTH receptor 1 agonist.新型甲状旁腺激素受体1激动剂依奈博帕肽的1期临床试验。
Endocr Connect. 2025 Jun 19;14(6). doi: 10.1530/EC-24-0464. Print 2025 Jun 1.
2
Pathophysiology of chronic kidney disease-mineral bone disorder (CKD-MBD): from adaptive to maladaptive mineral homeostasis.慢性肾脏病-矿物质与骨异常(CKD-MBD)的病理生理学:从适应性矿物质稳态到适应性不良的矿物质稳态。
Clin Kidney J. 2025 Mar 13;18(Suppl 1):i3-i14. doi: 10.1093/ckj/sfae431. eCollection 2025 Mar.
3
Exploring the Role of Hormones and Cytokines in Osteoporosis Development.

本文引用的文献

1
STUDIES OF CALCIUM AND PHOSPHORUS METABOLISM : V. A STUDY OF THE BONE TRABECULAE AS A READILY AVAILABLE RESERVE SUPPLY OF CALCIUM.钙磷代谢研究:V. 骨小梁作为钙的易动用储备供应源的研究。
J Exp Med. 1929 Jan 1;49(1):145-62. doi: 10.1084/jem.49.1.145.
2
Platelet-derived growth factor (PDGF)-AA: a self-imposed cytokine in the proliferation of human fetal osteoblasts.血小板衍生生长因子(PDGF)-AA:人胎儿成骨细胞增殖中的一种自身施加的细胞因子。
Cytokine. 2000 Aug;12(8):1271-4. doi: 10.1006/cyto.2000.0707.
3
In vivo regulation of apoptosis in metaphyseal trabecular bone of young rats by synthetic human parathyroid hormone (1-34) fragment.
探索激素和细胞因子在骨质疏松症发展中的作用。
Biomedicines. 2024 Aug 12;12(8):1830. doi: 10.3390/biomedicines12081830.
4
New Insights into Calorie Restriction Induced Bone Loss.热量限制导致的骨丢失新见解。
Endocrinol Metab (Seoul). 2023 Apr;38(2):203-213. doi: 10.3803/EnM.2023.1673. Epub 2023 Apr 27.
5
Abaloparatide Has the Same Catabolic Effects on Bones of Mice When Infused as PTH (1-34).阿巴洛帕拉替德在以与甲状旁腺激素(1-34)相同的方式输注时,对小鼠骨骼具有相同的分解代谢作用。
JBMR Plus. 2023 Jan 5;7(2):e10710. doi: 10.1002/jbm4.10710. eCollection 2023 Feb.
6
Dynamic Balance between PTH1R-Dependent Signal Cascades Determines Its Pro- or Anti-Osteogenic Effects on MSC.甲状旁腺素受体 1 依赖性信号级联的动态平衡决定了其对间充质干细胞成骨或抗成骨效应。
Cells. 2022 Nov 7;11(21):3519. doi: 10.3390/cells11213519.
7
Anabolic Bone Stimulus Requires a Pre-Exercise Meal and 45-Minute Walking Impulse of Suprathreshold Speed-Enhanced Momentum to Prevent or Mitigate Postmenopausal Osteoporosis within Circadian Constraints. anabolic 骨刺激需要在运动前用餐,并进行 45 分钟的超阈速度增强动量的步行脉冲,以在昼夜节律限制内预防或减轻绝经后骨质疏松症。
Nutrients. 2021 Oct 22;13(11):3727. doi: 10.3390/nu13113727.
8
Mechanical loading and parathyroid hormone effects and synergism in bone vary by site and modeling/remodeling regime.机械加载和甲状旁腺激素对骨骼的作用及其协同作用因部位和建模/重塑状态而异。
Bone. 2021 Dec;153:116171. doi: 10.1016/j.bone.2021.116171. Epub 2021 Sep 4.
9
The pathophysiology of immunoporosis: innovative therapeutic targets.免疫骨质疏松症的病理生理学:创新的治疗靶点。
Inflamm Res. 2021 Aug;70(8):859-875. doi: 10.1007/s00011-021-01484-9. Epub 2021 Jul 16.
10
Salt-inducible kinase 1 regulates bone anabolism via the CRTC1-CREB-Id1 axis.盐诱导激酶 1 通过 CRTC1-CREB-Id1 轴调节骨合成代谢。
Cell Death Dis. 2019 Oct 31;10(11):826. doi: 10.1038/s41419-019-1915-4.
合成人甲状旁腺激素(1-34)片段对幼鼠干骺端松质骨细胞凋亡的体内调节作用
Bone. 2000 Aug;27(2):209-18. doi: 10.1016/s8756-3282(00)00309-4.
4
Platelet-derived growth factor-AA and -alpha receptor expression suggests an autocrine and/or paracrine loop in osteosarcoma.血小板衍生生长因子-AA及α受体的表达提示骨肉瘤中存在自分泌和/或旁分泌循环。
Mod Pathol. 2000 Jun;13(6):632-7. doi: 10.1038/modpathol.3880109.
5
Involvement of osteoprotegerin/osteoclastogenesis inhibitory factor in the stimulation of osteoclast formation by parathyroid hormone in mouse bone cells.骨保护素/破骨细胞生成抑制因子在甲状旁腺激素刺激小鼠骨细胞破骨细胞形成中的作用。
Eur J Endocrinol. 2000 Jun;142(6):661-4. doi: 10.1530/eje.0.1420661.
6
In vivo demonstration that human parathyroid hormone 1-38 inhibits the expression of osteoprotegerin in bone with the kinetics of an immediate early gene.体内实验证明,人甲状旁腺激素1-38可抑制骨中骨保护素的表达,其动力学表现为即刻早期基因的特征。
J Bone Miner Res. 2000 May;15(5):863-71. doi: 10.1359/jbmr.2000.15.5.863.
7
Increased bone formation by prevention of osteoblast apoptosis with parathyroid hormone.甲状旁腺激素通过预防成骨细胞凋亡增加骨形成。
J Clin Invest. 1999 Aug;104(4):439-46. doi: 10.1172/JCI6610.
8
Parathyroid hormone stimulates TRANCE and inhibits osteoprotegerin messenger ribonucleic acid expression in murine bone marrow cultures: correlation with osteoclast-like cell formation.甲状旁腺激素刺激TRANCE并抑制小鼠骨髓培养物中骨保护素信使核糖核酸的表达:与破骨细胞样细胞形成的相关性。
Endocrinology. 1999 Aug;140(8):3552-61. doi: 10.1210/endo.140.8.6887.
9
Expression of stem cell factor by osteoblasts in normal and hyperparathyroid bone: relation to ectopic mast cell differentiation.正常及甲状旁腺功能亢进骨中骨细胞干细胞因子的表达:与异位肥大细胞分化的关系。
Virchows Arch. 1999 Jul;435(1):50-7. doi: 10.1007/s004280050394.
10
A randomized comparison of trapidil (triazolopyrimidine), a platelet-derived growth factor antagonist, versus aspirin in prevention of angiographic restenosis after coronary artery Palmaz-Schatz stent implantation.
Catheter Cardiovasc Interv. 1999 Feb;46(2):162-8. doi: 10.1002/(SICI)1522-726X(199902)46:2<162::AID-CCD10>3.0.CO;2-E.